Related Experiment Videos
Essential fatty acids: biochemistry, physiology and pathology
1UND Life Sciences, Shaker Heights, OH 44120, USA. undurti@hotmail.com
Biotechnology Journal
|August 8, 2006
Summary
Essential fatty acids (EFAs) are vital nutrients that require metabolism into specific long-chain forms for optimal health benefits. These compounds and their derivatives possess anti-inflammatory and cardiovascular protective properties, influencing numerous physiological and pathological processes.
Area of Science:
- Nutritional Biochemistry
- Molecular Biology
- Physiology
Background:
- Essential fatty acids (EFAs), including linoleic acid (LA) and alpha-linolenic acid (ALA), are crucial for human health and readily available in the diet.
- EFA deficiency is rare in humans, but their benefits are realized through metabolism into long-chain metabolites like arachidonic acid (AA) and docosahexaenoic acid (DHA).
Purpose of the Study:
- To explore the metabolic pathways of EFAs and their long-chain derivatives.
- To elucidate the diverse biological actions of EFAs and their metabolites, including anti-inflammatory, antihypertensive, and anti-atherosclerotic effects.
- To investigate the role of EFAs and their derivatives in various physiological and pathological conditions.
Main Methods:
- Literature review of studies on EFA metabolism and function.
- Analysis of research on the biochemical transformations of LA and ALA into their respective long-chain metabolites.
- Examination of evidence regarding the signaling pathways and cellular actions of EFAs and their derivatives, including interactions with nitric oxide (NO).
Main Results:
- EFAs are metabolized into dihomo-gamma-linolenic acid (DGLA), arachidonic acid (AA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA).
- These metabolites serve as precursors for prostaglandins, thromboxanes, leukotrienes, lipoxins, and resolvins, exhibiting potent anti-inflammatory effects.
- EFAs and their derivatives demonstrate potential roles as angiotensin-converting enzyme and HMG-CoA reductase inhibitors, NO enhancers, and possess antihypertensive and anti-atherosclerotic properties.
- EFAs react with NO to form nitroalkene derivatives, mediating cell signaling through peroxisome proliferator-activated receptors.
- Altered EFA metabolism is observed in diseases such as obesity, hypertension, diabetes, cardiovascular disease, schizophrenia, Alzheimer's disease, atherosclerosis, and cancer.
Conclusions:
- Essential fatty acids and their metabolites play multifaceted roles in human health and disease.
- Understanding EFA metabolism is critical for addressing various chronic diseases.
- EFAs and their derivatives represent a promising area for therapeutic interventions.